Advertisement
Advertisement

CADL

CADL logo

Candel Therapeutics, Inc. Common Stock

10.59
USD
Sponsored
+0.01
+0.09%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

10.58

-0.01
-0.11%

Candel Therapeutics, Inc. Common Stock Profile

About

Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company's product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass.

Info & Links

CEO

Paul Peter Tak

Headquarters

117 KENDRICK STREET, SUITE 450
NEEDHAM, MA 02494, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.candeltx.com

Auditor

KPMG LLP

Share holders

53

Employees

55

Candel Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

775.05M

Enterprise Value

627.69M

Enterprise Value/EBITDA(ttm)

-11.28

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.62

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-60.42%

Return on Invested Capital(ttm)

-53.71%

Return on Assets(ttm)

-41.33%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-55.67M

Net Income Available to Common(ttm)

-54.42M

Diluted EPS(ttm)

-0.98

Share Statistics

Beta (5Y Monthly)

-0.51

52-Week Change

81.34%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

73.27M

Dividend Yield

0.00%

Float4

62.79M

% Held by Insiders

14.30%

% Held by Institutions

13.93%

Balance Sheet

Total Cash(mrq)

194.83M

Total Cash Per Share(mrq)

2.66

Total Debt(mrq)

47.48M

Total Debt/Equity(mrq)

34.39%

Current Ratio(mrq)

28.05%

Quick Ratio(mrq)

28.05%

Book Value Per Share(mrq)

1.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.29

Free Cash Flow(ytd)

-18.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement